Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Whole Cell Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107746861A details a biocatalytic route for high-purity chiral alcohols. Discover cost-effective supply chain solutions for API intermediates.
Patent CN112011494A details a novel whole-cell catalytic route for Aspartame. This report analyzes the 95% yield and cost advantages for global supply chains.
Novel whole-cell catalytic method for 2'-fluoro-2'-deoxyadenosine. Reduces purification steps and enhances supply chain reliability for nucleic acid drug manufacturing.
Patent CN112501223B details a one-step enzymatic route for statin side chains, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN108441433A reveals biocatalytic route for high-purity chiral alcohol. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102757924A details a novel Rhodococcus strain for high-purity (S)-(+)-DMCPA production, offering superior enantioselectivity and scalable manufacturing for cilastatin synthesis.
Patent CN104313064A details a high-yield biocatalytic route for chiral esters. Discover cost-effective, scalable manufacturing for pharmaceutical intermediates.
Patent CN103642849A details a high-yield Geotrichum candidum reduction method for chiral intermediates, offering significant cost and supply chain advantages.
Patent CN105368828A enables high-yield UDCA synthesis via recombinant E. coli ensuring supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Patent CN102382780B reveals a novel Microbacterium oxydans strain for high-purity chiral alcohol production, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112063531B reveals a novel Geotrichum candidum strain for Ticagrelor intermediate synthesis, offering high stereoselectivity and reduced manufacturing costs.
Patent CN109180691B reveals an enzymatic route for C3-aromatic pyrroloindole alkaloids. This method offers high optical purity and scalable production for neuroprotective drug development.
Patent CN101565685A reveals a novel recombinant E. coli strain for producing chiral acetoin and 2,3-butanediol with high ee values, offering significant cost reduction in chiral chemical manufacturing.
Patent CN100376681C details a microbial asymmetric reduction method for (R)-mandelic acid using Saccharomyces cerevisiae, offering a green, cost-effective alternative to traditional chemical resolution for pharmaceutical manufacturing.
Novel biocatalytic route for (R)-1-(4-bromophenyl)-2,2,2-trifluoroethanol using Cyberlindnera saturnus. High ee, mild conditions, scalable pharma intermediate production.
Patent CN113462728A details a novel whole-cell biocatalytic route for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112048538B reveals a high-yield biocatalytic route for Aprepitant intermediates using Cyberlindnera saturns, offering superior purity and cost efficiency.
Patent CN113025544A reveals efficient whole-cell catalysis for L-phenyllactic acid. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102382780A reveals a novel Microbacterium oxydans strain for high-purity chiral alcohol production, offering significant cost reduction and supply chain stability for global API manufacturers.
Patent CN116199591A reveals high-purity levocarnitine synthesis via whole-cell catalysis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.